← Open Payments lookup

PRANAV BARVE: Open Payments

NPI 1972899839 · WILDOMAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,723 in 84 payments from 27 companies in 2025. Trend: 2023 $2,480 · 2024 $2,325 · 2025 $1,723

Food & beverage: $1,723
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$196
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$161
Sumitomo Pharma America, Inc.8$160
Corcept Therapeutics9$155
Amgen Inc.9$140
Dexcom, Inc.5$114
Novartis Pharmaceuticals Corporation5$101
Lundbeck LLC4$71
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Kowa Pharmaceuticals America, Inc.4$61

Products named: REXULTI, CAPLYTA, GEMTESA, Korlym, Dexcom G6 Transmitter, LEQVIO, OTEZLA, JARDIANCE.

Industry payments across CA — which companies pay providers there.